Nanotechnology for mesenchymal stem cell therapies
被引:25
作者:
Corradetti, Bruna
论文数: 0引用数: 0
h-index: 0
机构:
Univ Politecn Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy
Houston Methodist Res Inst, Dept Nanomed, 6670 Bertner Ave, Houston, TX 77030 USAUniv Politecn Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy
Corradetti, Bruna
[1
,2
]
Ferrari, Mauro
论文数: 0引用数: 0
h-index: 0
机构:
Houston Methodist Res Inst, Dept Nanomed, 6670 Bertner Ave, Houston, TX 77030 USA
Weill Cornell Med Coll, Dept Med, New York, NY 10065 USAUniv Politecn Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy
Ferrari, Mauro
[2
,3
]
机构:
[1] Univ Politecn Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy
[2] Houston Methodist Res Inst, Dept Nanomed, 6670 Bertner Ave, Houston, TX 77030 USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
Mesenchymal stemcells (MSC) display great proliferative, differentiative, chemotactic, and immune-modulatory properties required to promote tissue repair. Several clinical trials based on the use of MSC are currently under-way for therapeutic purposes. The aim of this article is to examine the current trends and potential impact of nanotechnology in MSC-driven regenerative medicine. Nanoparticle-based approaches are used as powerful carrier systems for the targeted delivery of bioactive molecules to ensure MSC long-term maintenance in vitro and to enhance their regenerative potential. Nanostructured materials have been developed to recapitulate the stem cell niche within a tissue and to instruct MSC toward the creation of regeneration-permissive environment. Finally, the capability of MSC to migrate toward the site of injury/inflammation has allowed for the development of diagnostic imaging systems able to monitor transplanted stem cell bio-distribution, toxicity, and therapeutic effectiveness. (C) 2015 Elsevier B.V. All rights reserved.